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Abstract: Vitamin C, one of essential micronutrients, has been reported to modulate the humoral immune responses in some 
mammals. We investigated whether vitamin C might modulate this response in mice by directly aff  ecting B cells. Splenic B 
cells were isolated and activated by CD40- and B cell receptor-ligation in vitro. Th   e cells were cultured with a pretreatment of 
vitamin C from 0 to 1 mM of concentrations. Vitamin C slightly increased apoptosis of B cells dose-dependently and behaved 
as an antioxidant. We found that in vivo administration of vitamin C by intraperitoneal injection aff  ected isotype switching as 
previously reported: the titer of antigen-specifi  c IgG1 antibody was decreased, while that of IgG2a was unaff  ected. Somewhat 
diff  erent from those observed in vivo, in vitro exposure to vitamin C slightly decreased isotype switching to IgG1 and increased 
isotype switching to IgG2a. Pretreatment with vitamin C in the safe range did not aff  ect either proliferation of cultured B cells or 
the expression of CD80 and CD86 in those cells. Taken together, in vivo results suggest that vitamin C acts to modulate isotype 
switching in the mouse. However, because of our in vitro results, we suggest that the modulation exerted by vitamin C in vivo is 
by indirectly aff  ecting B cells, perhaps by directly infl  uencing other immune cells such as dendritic cells.
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plays a role in modulating the antibody isotype switching. 
Administration of vitamin C lowered IgE levels in patients 
with chronic granulomatous disease (Anderson & Dittrich, 
1979) and in patients with bronchial asthma (Anderson et 
al., 1980). Vitamin C was also reported to lower IgG levels in 
calves but to increase in adult cows (Cummins & Brunner, 
1989). Previously, we demonstrated that administration of a 
mega-dose vitamin C to mice, at the time of immunization, 
remarkably lowered serum titers of two antigen-specifi  c Th  2 
isotypes, IgG1 and IgE (Noh et al., 2005). As is well known, 
antibody production results from concerted interactions 
among several immune cells including B cells, T cells, 
and dendritic cells. If vitamin C does modulate antibody 
production in B cells, either via its chemical or its antioxidant 
activities, it will be important to determine which immune 
cells vitamin C directly affects to influence this process. 
Because in vivo administered vitamin C modulates T cell 
behaviors such as proliferation and cytokine secretion (Noh 
et al., 2005), it could aff  ect T cells primarily. Or, it is equally 
Introduction
   
Vitamin C is an essential micronutrient synthesized 
from glucose. In the cell, vitamin C serves as a co-factor for 
enzymes involved in the biosynthesis of several molecules 
such as collagen fibers, carnitine, catecholamine, and some 
other neurotransmitters (De Tullio, 2002; Patak et al., 2004), 
and also acts as a physiological antioxidant (Long & Santos, 
1999). These activities of vitamin C affect a wide range of 
biological processes (Mandl et al., 2009 ). 
Vitamin C also affects immune responses in several 
aspects. There are some reports indicating that vitamin C Anat Cell Biol 43:25~35, 2010 Ami Woo, et al 26
www.acbjournal.com doi: 10.5115/acb.2010.43.1.25
possible that vitamin C acts directly on dendritic cells to 
modulate the B cell functions by way of T cells (Pearce et al., 
2006).
Alternatively, vitamin C may influence antibody 
production as a direct effect on B cells by modulating the 
level of intracellular reactive oxygen species (ROS) in these 
cells. Some reports have suggested that antioxidants might 
regulate B cell activation and functions including isotype 
switching. N-acetyl-L-cysteine (NAC), an antioxidant, 
was shown to inhibit both the up-regulation of CD40 
and the isotype switching to IgE by IL-4 (Yanagihara et 
al., 1997), and also to affect in vitro B cell proliferation 
induced by CD40 ligation (Lee, 2003). NAC treatment of B 
cells from Atm
-/- mice was shown to lower the increased 
levels of intracellular ROS and thus to rescue the impaired 
immunoglobulin isotype switching in these mice (Ito et al., 
2007). Th   e tabacco polyphenols, quercetin and rutin, which 
are antioxidants, were shown to inhibit antigen-presenting 
functions of B lymphoma cells (Gong & Chen, 2003). Based 
on these fi  ndings, the role of ROS in B cell functions has been 
suggested, and thus vitamin C, an important physiological 
antioxidant that reduces intracellular ROS levels (Blumenthal 
et al., 2000; Guaiquil et al., 2001), would directly modify their 
behaviors and functions. 
It has never been studied whether vitamin C directly 
aff  ects B cells with respect to isotype switching. Furthermore, 
even the effects of vitamin C on B cell activation such as 
proliferation and surface molecule expression have not been 
reported. In the present study, we isolated mouse splenic B 
cells and evaluated the direct effects of vitamin C on these 
cells following in vitro activation. 
Materials and Methods
Experimental animals
Eight to ten-week-old male Balb/c mice were purchased 
from BioLink (Seoul, Korea) and were kept in animal facilities 
of Seoul National University, College of Medicine (Seoul, 
Korea). They were reared in a 12 hour light-dark cycle and 
were given usual mice chow and tap water ad libitum. This 
animal study was approved by our institutional IACUC 
(approval number; SNU-060926-3) and all the procedures 
were performed following the SOP of our Institute.
Immunization with keyhole limpet hemocyanin 
(KLH) and quantifi  cation of specifi  c antibody titers in 
vivo
Mice were immunized twice, on days 1 and 21, with an 
intraperitoneal injection of 100 μg of KLH (Sigma Chemical 
Co., St Louis, MO) in 200 μl PBS. Vitamin C (as L-ascorbic 
acid, Sigma), either at a dose of 0.625 mg/mouse or 5 mg/
mouse was given daily by intraperitoneal injection for 3 
days before primary immunization and also every day after 
primary immunization for 10 more days. This protocol is 
based on our previous experiment (Noh et al., 2003). No 
vitamin C was administered around secondary immunization. 
Seven days aft  er the secondary immunization, blood samples 
were drawn from the orbital plexus under anesthesia. Sera 
were obtained and then stored at 4
oC until used. 
Titrations of KLH-specific antibodies in sera were 
determined by ELISA as follows. Ninety six well ELISA plates 
(Nunc, Rochester, NY) were coated with 100 μl of 2 μg/ml 
KLH/well. Plates were incubated for 5 hours at 37
oC, and then 
overnight at 4
oC. Th   e subsequent steps were identical to those 
used below for the analysis of antibody production in cultures, 
but there were two differences: the serum samples were 
diluted 1 : 20 (in 1% skim milk/PBS containing 0.05% Tween 
20), and KLH-specifi  c anti-serum was used as a standard in 
these experiments. Titers were expressed as relative values to 
standard serum. Th   e relative value of the standard serum was 
regarded as 2.5.
Isolation and activation of resting B cells in culture
The mice were sacrificed by cervical dislocation. Their 
spleens were obtained, chopped, and minced so that the 
cells could be harvested. The RBCs were lysed using lysis 
buffer (0.83% NH4Cl in 0.01 M Tris-HCl buffer, pH 7.5). 
Th   e adhering cells were removed by incubating in a 100 mm 
culture dish for 1 hour in a 37
oC humidifi  ed CO2 incubator. 
After then, B cells were isolated by negative selection using 
MACS CD43 (Ly-48) MicroBead (Miltany Biotech, Germany) 
following the manufacturer’s manual. The purity was over 
95% as was assessed by FACS analysis using FITC-conjugated 
anti-mouse CD19 antibody (BD Pharmingen, San Diego, 
CA). Isolated B cells were cultured in RPMI 1640 medium 
containing 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 
mM non-essential amino acid, 10 mM HEPES (pH 7.4), 
100 μg/ml streptomycin and 100 U/ml penicillin, 5×10
-5 
mM 2-ME, and 10% FBS. All cultures were carried out in a 
humidifi  ed CO2 incubator at 37
oC. B cells were activated by Indirect modulation of isotype switching by vitamin C 
in mouse B cells
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applying goat F(ab’)2 anti-mouse IgM (1 μg/ml, Southern 
Biotech, Birmingham, AL) and rat anti-mouse CD40 (1 
μg/ml, BD Pharmingen, San Diego, CA) antibodies to the 
culture. Th   is was intended to mimic in vivo B cell activation 
by ligation of B-cell receptors and CD40 (Baumgarth, 2000).
Apoptosis assay  
To assess whether experimental concentrations of vitamin 
C used in the culture media would provoke B cell apoptosis, 
we performed Annexin V/PI staining and flow cytometric 
analysis. B cells were seeded in a 24-well plate at a density of 
1×10
6 cells/well. Parallel cultures of cells were pre-treated with 
L-ascorbic acid (Sigma, St. Louis, MO) at a concentration 
of 0, 0.0625, 0.125, 0.25, 0.5 or 1 mM for 1 hour, and then 
activated. Twenty-four hours after activation, B cells were 
harvested, washed with PBS, and centrifuged. Supernatants 
were discarded and 400 μL of Annexin V binding buff  er (BD 
Pharmingen, San Diego, CA) at working dilution was added 
and the cells were re-suspended. Each sample was added with 
2 μL (per 1×10
6 cells) of Annexin V-FITC (BD Pharmingen) 
and incubated for 15 minutes at room temperature with mild 
agitation. After then, 0.1 μg (per 1×10
6 cells) of propidium 
iodide (PI, BD Pharmingen) in 2 μL volume was added to 
each sample. Cells were analyzed using a flow cytometer 
(Becton Dickinson, San Jose, CA).
Measurement of intracellular ROS levels
To evaluate antioxidant eff  ects of vitamin C, intracellular 
ROS levels were measured using the fluorescence probe, 
2’,7’-dichlorofluorescein diacetate (DCFH-DA) (Wan et al., 
1993). B cells were seeded 1×10
6 cells/ml in a 24-well plate. 
Th   e cells were incubated with 50 μM DCFH-DA (Sigma, St. 
Louis, MO) for 30 minutes at 37
oC and then washed with ice-
cold PBS. Next, the cells were seeded in 96-well plates at a 
cell density of 4×10
5 cells/well and pretreated for 1 hour with 
a specific concentration of L-ascorbic acid (Sigma). Each 
culture, in parallel, was exposed to a single concentration of 
vitamin C at increments within the range from 0.0625 mM to 
1 mM. Next, the cells were activated as described above and 
the fl  uorescence was measured for 1 hour by using Cytofl  uor 
2350 plate reader (Millipore, Bedford, MA). Excitation and 
emission frequencies were 485 nm and 538 nm, respectively. 
Values for each time point were obtained by subtracting the 
value at time 0 from each raw value.
Proliferation assay
B cells were seeded in 96-well plates at 4×10
5 cells/well. 
Parallel cultures of cells were pre-treated with vitamin C at a 
concentration of 0, 0.0625, 0.125, or 0.25 mM for 1 hour, and 
activated for 48 hours as described above. One μCi/well of [
3H] 
thymidine (Amersham Pharmacia Biotech, Oslo, Norway) 
was then added to the culture and incubated for additional 18 
hours. The cells were harvested on glass-fiber filters using a 
cell harvester (INOTECH). Radioactivity was counted with a 
scintillation β-counter (MicroBeta Trilux, Perkin Elmer). All 
samples were prepared in triplicate. 
Analysis of the expression of cell surface molecules 
using fl  ow cytometry
Purified B cells were plated at 1×10
6 cells/well in 24-well 
plates. Cells were pretreated with vitamin C for 1 hour, and 
then activated for 24 hours. The cells were then harvested, 
double-stained for B220 and for the expressions of surface 
molecules, CD80 or CD86. Anti-B220-PE, CD80-FITC, and 
anti-CD86-FITC antibodies (BD Pharmingen, San Diego, 
CA) were used at 2 μg/1×10
6 cells. Aft  er 30 minute incubation 
at room temperature, the cells were washed and analyzed 
using a fl  ow cytometer (Becton Dickinson, San Jose, CA).
Analysis of antibody production in cultures 
B cells were seeded in a 24-well plate at a density of 1×10
6 
cells/well, activated as mentioned above, and cultured for 6 
days. Before activation, B cells were pre-treated with vitamin 
C at a specific concentration, and supplemented with the 
same concentration of vitamin C every 2 days until the end 
of culture. Supernatants were collected and then stored at 4
oC 
until used. Th   e titers of total, IgG1, and IgG2a antibodies in 
the supernatants were determined by ELISA as follows. Ninety 
six well ELISA plates (Nunc, Rochester, NY) were coated 
with 100 μl goat anti-mouse polyvalent immunoglobulin 
(diluted at 1 : 1,000, Sigma, M8019). Plates were incubated 
for 5 hours at 37
oC, and then incubated overnight at 4
oC. 
Plates were then briefly washed and then blocked with 1% 
skim milk in PBS for 1 hour at room temperature. A neat 
concentration of supernatants was applied to the fi  rst row of 
the ELISA plate, and 4-fold serially diluted. All samples were 
prepared in duplicate. Th   e plates were incubated for 2 hours 
at room temperature, followed by incubation with alkaline 
phosphatase-conjugated secondary antibodies for each isotype 
for 1 hour, and by p-nitrophenyl phosphate substrate (Sigma, 
St. Louis, MO) solution. OD values were measured at 405 Anat Cell Biol 43:25~35, 2010 Ami Woo, et al 28
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nm. Th   e secondary antibody used was as follows; goat anti-
mouse polyvalent immunoglobulin (1 : 1,000 diluted, Sigma), 
goat anti-mouse IgG1, or IgG2a antibody (1 : 1,000 diluted, 
Southern Biotech, Birmingham, AL). A single batch of pooled 
sera from mice immunized with keyhole limpet hemocyanin 
in the previous experiments was used as a standard for 
the titration of total immunoglobulin, and the titers in the 
supernatant were expressed as relative values to this standard 
serum. In this case, the relative value of the standard serum 
was regarded as 1,000. For IgG1 and IgG2a titrations, purifi  ed 
IgG1 or IgG2a antibody of a known concentration was used 
respectively. 
Statistical analysis
Statistical analysis was performed using Student T-test or 
Wilcoxon rank sum test using SPSS software (Version 11). 
Signifi  cance was set at P<0.05.
Results
Injected vitamin C decreased the antigen-specifi  c 
IgG1 titer in mice sera
Before evaluating direct eff  ects of vitamin C on B cells in 
vitro, we repeated our previous in vivo experiment (Noh et 
al., 2005) to reproduce the in vivo effects of supplemented 
vitamin C on the humoral immune responses. Mice were 
immunized with KLH in one of four ways: 1) with no other 
treatment (normal control), 2) with concomitant injections of 
PBS (experimental control), 3) with 0.625 mg of vitamin C, 
or 4) with 5 mg of vitamin C, as was described in Materials 
and Methods. These doses are equivalent to 1.5 g and 12 
Fig. 1. Administration of vitamin C in vivo markedly reduced serum IgG1 titer. Mice were injected with nothing (control group), PBS, 0.625 mg, 
or 5 mg of vitamin C during primary immunization with 100 μg Keyhole limpet hemmaglutinin (KLH). Seven days aft  er second immunization 
on day 21, sera were obtained and ELISA was performed for titration of total, IgG1, and IgG2a KLH-specifi  c antibodies. Titers are expressed as 
relative units to standard serum, which was regarded as 2.5. IgG1 titers of two vitamin C-injected groups were signifi  cantly lower (*) that that of 
PBS-injected group (P=0.018 and 0.012, respectively). Values are mean±SD (n=8 in each group). Indirect modulation of isotype switching by vitamin C 
in mouse B cells
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g/60 kg body weight in human, respectively. Each group of 
mice was given a second immunization on day 21. For each 
group, the titers of the total KLH-specific antibodies were 
determined (Fig. 1A). Th   e average titers in the three injected 
groups (groups 2~4) were lower than that of normal control 
group. However, the diff  erence was not statistically signifi  cant 
(P>0.05). Th   e titers of KLH-specifi  c IgG2a (Fig. 1B) showed a 
similar pattern to that of the total antibody titers. Th   at is, the 
average IgG2a titers in all three injected groups were lower 
than that of normal control group. In this case, the diff  erence 
was statistically significant (P<0.05). However, statistically 
significant differences were not observed between the PBS-
injected group and vitamin C-injected groups. The titers of 
IgG1 (Fig. 1C) showed a diff  erent pattern. For each group, the 
tires were 1) 20.6±9.6, 2) 13.9±5.7, 3) 2.1±1.4, and 4) 0.7±0.3. 
The groups of mice injected with vitamin C (3 and 4) had 
titers that were signifi  cantly lower than those of both control 
groups (1 and 2) (P<0.05). Th   ese results revealed that vitamin 
C modified humoral immune responses. Thus, we further 
evaluated whether vitamin C directly aff  ects B cell functions. 
Vitamin C slightly induced apoptosis of activated B 
cells dose-dependently
Vitamin C at certain concentrations in culture media 
is known to be cytotoxic leading to apoptosis in many cell 
types (Duarte & Lunec, 2005). Therefore, we tested a range 
of vitamin C concentrations to define a range that could be 
safely used on B cells without aff  ecting viability. B cells were 
pre-treated with increasing concentrations of vitamin C for 1 
hour and activated with anti-IgM and anti-CD40 antibodies. 
Twenty-four hours after activation, cells were stained with 
Annexin V and propidium iodide. With this method, the 
viability of cells cultured in the absence of vitamin C was 
93.6%. Th   e viability of cells cultured with vitamin C decreased 
by about 3% with doubling of the vitamin C concentration, 
reaching 77.1% at a vitamin C concentration of 1 mM (Fig. 2).
Vitamin C decreased intracellular ROS levels in 
activated B cells
At higher concentrations, vitamin C could exert a pro-
oxidant effect instead of an anti-oxidant effect (Clément et 
al., 2001). Thus we next evaluated the concentration range 
with which vitamin C acts as an anti-oxidant in B cells by 
measuring intracellular ROS levels. B cells were pretreated 
for 1 hour with a concentration of vitamin C within the 
range from 0.0625 mM up to 1 mM, and then activated. In 
the control culture without vitamin C, intracellular ROS 
levels were elevated (Fig. 3) and continued to rise over time. 
Cultures treated with vitamin C within the range of 0.0625 to 
0.5 mM showed a decrease in the levels of ROS compared to 
that of the 0 mM group (P<0.05). Cultures treated with 1 mM 
vitamin C behaved diff  erently. Th   ese cultures did have a lower 
level of ROS compared to the control culture. However, the 
level was still higher than the other cultures that were exposed 
to lower concentrations of vitamin C (P<0.05). 
Because the concentrations between 0.0625 mM and 
Fig. 2. Vitamin C slightly induced 
apoptosis of activated B cells dose-
dependently. B cells were seeded at a 
density of 1×10
6/well in 24-well plates 
and pre-incubated for 1 hour with 
varying concentrations of vitamin C 
as indicated. Cells were then activated 
with anti-IgM and anti-CD40 anti-
bodies for 24 hours, were harvested 
and stained with Annexin V-FITC and 
propidium iodide, and flowcytometric 
analysis was performed. The concen-
trations of vitamin C are marked at 
the top of each panel. The data are 
representative of three independent 
experiments. Anat Cell Biol 43:25~35, 2010 Ami Woo, et al 30
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0.25 mM exhibited antioxidant properties and tolerable 
cell viabilities, and because these concentrations cover the 
physiological serum concentration of vitamin C, we used 
these concentrations for further experiments.
Vitamin C did not aff  ect the proliferation of activated 
B cells vitro
For exploration of the effects of vitamin C on B cell 
functions, we first evaluated whether vitamin C exerted 
direct eff  ects on the proliferation following B cell activation. 
Isolated B cells were pretreated with vitamin C and activated 
for 48 hours. Thymidine was added and the cultures were 
incubated for an additional 18 hours. As is shown in Fig. 4, 
the presence of vitamin C at any concentration did not aff  ect 
B cell proliferation. 
Vitamin C did not aff  ect the expressions of CD80 and 
CD86 in activated B cells
As B cells are being activated, they up-regulate surface 
expression of co-stimulatory molecules such as CD80 and 
CD86. Thus we evaluated whether vitamin C given at the 
time of activation aff  ected the expressions of these molecules. 
CD80 levels increased from 13.5% before activation to 18.4%, 
aft  er activation in control cultures. CD86 levels also increased 
from 8.8% to 31.9% in control cultures (Fig. 5). In cultures 
pretreated with vitamin C, the levels of both CD80 and CD86 
aft  er activation were similar to the control group. Th  ere  may 
have been a slight increase in CD86 levels (Fig. 5) in cultures 
pretreated with vitamin C. However, those results were not 
reproduced and so were regarded as not signifi  cant.
Vitamin C modifi  ed isotype switchings in B cells 
activated in vitro
B cells were activated and then cultured for 6 days in either 
the presence or absence of vitamin C in the culture media. 
Supernatants were collected and an ELISA was performed to 
quantify the titers of IgG1 and IgG2a isotypes (Fig. 6). The 
titer of total immunoglobulins (upper panel) was not aff  ected 
by the presence of vitamin C. For IgG1 (middle panel), the 
titer slightly decreased as the dose of vitamin C increased 
up to 0.25 mM with statistical signifi  cance compared to the 
control group (76.6±3.0 vs 59.2±1.6, P<0.05). The titer of 
IgG2a (lower panel), in contrast to that of IgG1, elevated as 
the dose of vitamin C increased up to 0.25 mM with statistical 
signifi  cance compared to the control group (32.3±1.7 vs 49.3 
±1.2, P< 0.05). 
Fig. 3. Vitamin C lowered ROS levels in activated B cells. B cells were 
loaded with 50 μM DCFH-DA for 30 minutes, and then washed and 
plated to 96-well plates at a density of 4×10
5 cells/well. After that, 
cells were pre-treated with vitamin C at concentrations indicated 
(mM) for 1 hour before activation with anti-IgM and anti-CD40 
antibodies. The fluorescence intensities were measured with 485 nm 
and 538 nm of excitation and emission frequencies, respectively. At 60 
minutes, cultures treated with 0.0625 to 0.5 mM vitamin C lowered 
intracytoplasmic level of ROS compared to that of the 0 mM group 
(P<0.05). For 1 mM group, the ROS level was still lower than that of 0 
mM group (P<0.05), but higher than those of other vitamin C-treated 
groups (P<0.05). Values represent mean±SD of triplicate wells, from a 
typical one out of three independent experiments. 
Fig. 4. Vitamin C did not aff  ect the proliferation of activated B cells. 
B cells in 96-well plates at a density of 4×10
5 cells/200 μL/well were 
activated with anti-IgM and anti-CD40 antibodies in the presence or 
absence of vitamin C. Aft  er 48 hours, cells were pulsed with 1 μCi of 
3H-thymidine for an additional 18 hours. Vitamin C did not induce 
signifi  cant change of proliferating ability of activated B cells (P>0.05). 
Values represent mean cpm±SD of triplicate cultures. Indirect modulation of isotype switching by vitamin C 
in mouse B cells
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Discussion
Th   is study was carried out to evaluate whether vitamin C 
exerts direct eff  ects on B cells following activation. Th  erefore, 
we chose to perform our experiments using an in vitro 
system. This system allowed us to directly apply vitamin C 
to isolated B cells and monitor several properties of B cell 
functions upon activation. We tried concentrations of vitamin 
C from 0.0625 mM, which is the lower limit of physiological 
serum concentration in mice (Dubick et al., 1983; Dubick 
et al., 2002; Kuo et al., 2004) up to 1 mM, which can be 
achieved by intravenous infusion for the management of 
malignancy in human (Padayatty et al., 2006; Hoffer et al., 
2008) or intraperitoneal injection of ascorbic acid in mice 
(Noh et al., 2003). However, because it is known that vitamin 
C is oxidized in culture media to produce hydrogen peroxide, 
which exerts oxidative stress to the cells leading to cell death 
(Duarte & Lunec, 2005), and because the susceptibility to 
this cytotoxic effects of vitamin C in culture media differ 
according to cell type, we determined the upper level of 
concentrations that does not reveal cytotoxic eff  ects on B cells 
in vitro (Fig. 2, 3) as 0.5 mM.
Vitamin C at a safe range of concentrations behaved as 
an antioxidant in activated B cells, but did not affect cell 
proliferation and surface molecule expressions. However, 
vitamin C modified isotype switching in cultured B cells, 
which was somewhat different from those observed in vivo 
(Fig. 1). That is, the decrease of IgG1 titers with in vivo 
vitamin C treatment was quite remarkable (Fig. 1), in contrast 
to those observed in in vitro experiments (Fig. 6), which 
was just slight. Furthermore, we could not observe elevated 
IgG2a levels in in vivo experiments, which were shown in in 
vitro experiments. Th   at could suggest that the modulation of 
in vivo isotype switching by vitamin C administration was 
by influencing the immune cells other than B cells, not by 
directly acting on B cells. 
There are some reports that could indicate direct effects 
of vitamin C in activated B cells to infl  uence their functions 
such as proliferation and/or expression of surface molecules. 
For example, it can be assumed that vitamin C might change 
the cell behaviors by modulating NF-κB activity in activated 
B cells, because vitamin C has been reported to inhibit NF-
κB activation in a several kind of cells (Bowie & O’Neill, 
2000; Han et al., 2004), and activation of NF-κB has been 
reported to be important in B cell activation (Basso et al., 
2004; Haxhinasto & Bishop, 2004; Weil & Israël, 2004). 
Fig. 5. Vitamin C did not aff  ect the expression of CD80 and CD86 molecules on activated B cells. B cells were pre-treated with vitamin C of 
various concentrations as indicated for 1 hour and then activated with anti-IgM and anti-CD40 antibodies. Cells were harvested and stained for 
surface expression of co-stimulatory molecules, CD80 and CD86, and were analyzed by fl  ow cytometry. Th   e numbers in each panel indicate the 
ratio of B220 and either CD80 or CD86 double positive cells. Th   e concentrations of vitamin C are marked at the top of each panel. Th   e data are 
representative of three independent experiments. Anat Cell Biol 43:25~35, 2010 Ami Woo, et al 32
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Furthermore, When B cells from NF-κB2 (-/-) mouse 
are activated κ, proliferation is reduced to half of the wild 
type B cells (Caamaño et al., 1998). Also, the expression of 
CD80, following CD40 ligation, is highly dependent to NF-
κB (Bishop & Hostager, 2001). The second putative way of 
vitamin C to directly modulate the behaviors of activated 
B cells could be through its antioxidant property. Reactive 
oxygen species (ROS) behave as a secondary signal messenger 
in a variety of biological responses (Dröge, 2002; Bubici et al., 
2006; Pantano et al., 2006), thus antioxidants which reduce 
intracellular ROS levels have been shown to modify cell 
behaviors. For example, NAC, a representative antioxidant, 
was shown to inhibit TNF-α-induced CD40 expression in the 
immature murine DC cell line, BC1 (Iijima et al., 2003), and 
blocked the expression of high levels of surface molecules 
such as MHCs, B7-1, and B7-2 after lipopolysaccharide 
treatment in human DC (Nouri-Shirazi & Guinet, 2002). 
Similarly, oxidant generating enzyme inhibitors, such as 
diphenyleneiodonium and allopurinol, suppressed high 
expression of MHC class II, CD40, and CD80 in rat Kupff  er 
cells aft  er antigen challenge (Maemura et al., 2005). Th  us  we 
expected that vitamin C would modulate the behaviors of 
mouse activated B cells, either by way of NF-kB activation 
inhibition or by lowering intracellular ROS levels.
Contrary to what we expected, vitamin C applied at non-
cytotoxic concentrations did not aff  ect either the proliferation 
of B cells or the surface expression of activation markers, 
CD80 and CD86 (Fig. 4, 5). We observed the expression 
of both CD80 and CD86 at 72 hours and 48 hours after 
activation respectively, at the times when their expression 
normally peaks (Bhatia et al., 2006). We found that there were 
no diff  erences between cells cultured either with or without 
vitamin C (data not shown). 
This could be explained in at least two ways. The 
antioxidant activity of vitamin C may not be strong enough 
to induce changes in these particular B cell behaviors. In 
our experiments, vitamin C did lower ROS levels in B 
cells. However, regardless of the concentration of vitamin 
C applied, the levels of ROS decrease were similar (Fig. 3) 
This may indicate that the cellular redox state reached an 
equilibrium level that was not enough to aff  ect cell behaviors. 
Another possibility is that the above-mentioned effects of 
Fig. 6. Th  e  in vitro eff  ects of vitamin C on immunoglobulin production 
by activated B cells. B cells in 24-well plates at a density of 1×10
6 cells/1 
mL/well were pre-treated with vitamin C, activated with anti-IgM and 
anti-CD40 antibodies, and cultured for 6 days. Vitamin C was added 
repeatedly every second day during culture periods. Cell supernatants 
were collected and the titers were determined for total Ig, IgG1, and 
IgG2a by ELISA. Results for total immunoglobulin are expressed 
as relative values to standard serum, which was regarded as 1,000 as 
described in MATERIALS AND METHODS. Values are mean±SD 
of triplicate culture wells. *P<0.05.Indirect modulation of isotype switching by vitamin C 
in mouse B cells
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several antioxidants on B cells might be by their action in 
chemical reactions, not by lowering ROS levels. In fact, NAC 
may increase the proliferation of human tonsillar B cells via 
the chemical activity of its thiol residues (Jeannin et al., 1995).
Little is known about how either vitamin C or ROS might 
affect the process of isotype switching in B cells. Recently, 
it was reported that high intracellular ROS levels in Atm-/- 
mutant mice inhibited isotype switching. Th   is inhibition could 
be rescued by NAC treatment (Ito et al., 2007). Based on this 
result, it may be suggested that low levels of ROS, induced by 
antioxidants like vitamin C, could promote isotype switching. 
In support of this idea, we observed increased isotype 
switching to IgG2a and decreased isotype switching to IgG1 
in B cells cultured with vitamin C (Fig. 6). These changes 
of isotypes elicited by vitamin C are in accordance with the 
previously reported Th  1  shift  ing eff  ects of vitamin C (Lee at 
al., 2008). However, the features of isotype switching observed 
in vitro is somewhat diff  erent from those observed in vivo. As 
previously reported (Noh et al., 2005), and reproduced in the 
present study, intraperitoneal injection of vitamin C markedly 
lowered the level of IgG1 isotype, without aff  ecting the level 
of IgG2a. How might vitamin C infl  uence isotype switching 
in vivo? It is known that the direction of switching in B cells is 
mainly determined by cytokines secreted by T cells (Manis et 
al., 2002; Pan-Hammarström et al., 2007). It could be possible 
that vitamin C may act directly on T cells, which then 
influence isotype switching in B cells. However, it does not 
seem to be the case, based on our recent results (Maeng et al., 
2009), in which in vitro treatment of vitamin C did not induce 
any changes with respect to Th  1/Th   2 polarization. Alternately, 
it is possible that vitamin C directly acts on dendritic cells, 
which in turn affect T cells, to modulate isotype switching. 
ROS are involved in dendritic cell differentiation and 
activation. Additionally, some antioxidants have been shown 
to aff  ect certain behaviors of dendritic cells, such as cytokine 
secretion, surface molecule expression, and T cell priming 
capacity (Iijima et al., 2003; Nouri-Shirazi M & Guinet E, 
2002; Lee et al., 2007). Also, ROS are generated when antigens 
are presented (Maemura et al., 2005) and NAC added at the 
time of antigen presentation modulates proliferation and 
cytokine secretion of T cells (Verhasselt et al., 1999). Thus, 
dendritic cells could be primarily aff  ected by vitamin C and in 
turn modulate isotype switching by way of T cells. Th  ese  need 
further investigations.
To summarize, vitamin C did not affect proliferation, or 
CD80 and CD86 expression in cultures of activated B cells. 
Vitamin C promoted isotype switching to IgG2a in vitro. 
However, the in vivo effect on isotype switching was not 
the same. Thus, even though it is possible that vitamin C 
treatment could promote isotype switching by directly acting 
B cells in vivo, it is more likely that vitamin C influences 
isotype switching by acting on other immune cells, most 
probably dendritic cells. 
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